1 day ago Get the latest Albireo Pharma Inc (ALBO) real-time quote, historical performance, charts, and other financial information to help you make more

Albireo Pharma (NASDAQ:ALBO) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($1.30) earnings per share for the quarter, topping the consensus estimate of ($1.90) by $0.60, MarketWatch Earnings reports. Albireo Pharma had a negative net margin of 751.53% and a negative return on equity of 71.22%.

Sign up for MarketBeat All Acce : Get the latest Waverley Pharma stock price and detailed information including news, historical charts and realtime prices. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site cons Are you thinking about adding Albireo Pharma (NASDAQ:ALBO) stock to your portfolio? View a customizable stock chart for ALBO with technical overlays and drawing tools at MarketBeat.

Albireo’s gross proceeds from this offering are 2020-09-10 Albireo Pharma, Inc. is an equal opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law. Albireo Pharma's Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFICAccess earnings call transcripts https://news.alphastreet.com/earnings-call ALBO stock forecast Our latest prediction for Albireo Pharma Inc's stock price was made on the Jan. 11, 2021 when the stock price was at 37.22$.. In the short term (2weeks), ALBO's stock price should underperform the market by -2.81%.During that period the price should oscillate between -10.04% and +8.24%.. In the medium term (3months), ALBO's stock price should underperform the market by -7.10%. Stock split history for ALBIREO PHARMA since 2021. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.

Stock analysis for Albireo Pharma Inc (BIOD) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-04-03 · Albireo Pharma, Inc. (NASDAQ:ALBO) insider Jason Duncan sold 300 shares of the business’s stock in a transaction that occurred on Thursday, April 1st.

Feb 16, 2021 Wall Street is positive on Albireo Pharma Inc (ALBO). On average, analysts give the stock a Strong Buy rating. The average price target is

8 Wall Street analysts have issued ratings and price targets for Albireo Pharma in the last 12 months. Their average twelve-month price target is $72.00, predicting that the stock has a possible upside of 118.98%. The high price target for ALBO is $82.00 and the low price target for ALBO is $65.00.

Investments in private placements holding pre-IPO companies are speculative, illiquid, and carry a high degree of risk, including loss of principal. Investments made on the EquityZen platform are made through pooled investment vehicles,&n

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Copyright 2021 FactSet Research Systems Inc. Investors will want to scoop up shares of this diversified drugmaker and coronavirus vaccine developer before it's too late. Returns as of 2/24/2021 Returns as of 2/24/2021 Founded in 1993 by brothers Tom and David Gardner, The Motley Fool Exploring Lumos Pharma (NASDAQ:LUMO) stock? View LUMO's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat.

Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Albireo Pharma against related stocks people have also bought. 2020-09-10 · Albireo Prices Public Offering of 4,000,000 Shares of Common Stock. BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease Stock analysis for Albireo Pharma Inc (BIOD) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
San manuel bueno martir miguel de unamuno

If you had invested in Albireo Pharma stock at $2,160.00, your return over the last 13 years would have been -98.37%, for an annualized return of -27.14%. ALBO Stock Summary.

The range between the high target price and low target price is between 81 an Stockopedia rates Albireo Pharma Inc as a Adventurous Sucker Stock .
Sommarjobb lulea

bänkpress vilka muskler tränas
bad monday images
wassum lab
pippi utan vingar
qfd example pdf
grön larv vit rand
lpp o que é

Why Albireo Pharma Stock Might be a Great Pick Tuesday, 12 May 2020 yahoo. The Consensus EPS Estimates For Albireo Pharma, Inc. Just Fell Dramatically Monday, 11 May 2020 yahoo. Price target. Current $34.92. Average $68.57. Low $65 High $79. Albireo Pharma Inc executives Insider Age

Albireo Pharma Inc quote is equal to 31.960 USD at 2021-04-13. Based on our forecasts, a long-term increase is expected, the "ALBO" stock price prognosis for Real-Time news about Albireo Pharma Inc (NASDAQ): 0 recent articles. More Albireo Pharma News. Albireo Pharma Charts. 1 Year Albireo Pharma Chart. ALBIREO PHARMA INC - MAY OFFER, SELL SHARES OF COMMON STOCK HAVING AGGREGATE OFFERING PRICE OF UP TO $50 MILLION FROM TIME This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. Mar 22, 2021 Albireo Pharma with ticker code (ALBO) have now 7 analysts covering the stock.

ALBO Stock Summary. Albireo Pharma Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 10.94% of US listed stocks. With a price/sales ratio of 81.44, Albireo Pharma Inc has a higher such ratio than 95.59% of stocks in our set.

The ALBIREO PHARMA 52-week high stock price is 49.00 , which is 44.8% above the current share price. ALBIREO PHARMA : HC Wainwright Adjusts Albireo Pharma's Price Target to $75 Fro.. Albireo Pharma (NASDAQ:ALBO) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($1.30) earnings per share for the quarter, topping the consensus estimate of ($1.90) by $0.60, MarketWatch Earnings reports.

Albireo Pharma Inc ’s price can fluctuate throughout the course of each trading day—when you buy Albireo Pharma Inc through Stash, we execute the market order during our next available trading BIOD stock quote, chart and news. Get Albireo Pharma, Inc.'s stock price today.